Elevated Levels of Shed Membrane Microparticles With Procoagulant Potential in the Peripheral Circulating Blood of Patients With Acute Coronary Syndromes
- 29 February 2000
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 101 (8), 841-843
- https://doi.org/10.1161/01.cir.101.8.841
Abstract
Background—Apoptotic microparticles are responsible for almost all tissue factor activity of the plaque lipid core. We hypothesized that elevated levels of procoagulant microparticles could also circulate in the peripheral blood of patients with recent clinical signs of plaque disruption and thrombosis.Methods and Results—We studied 39 patients with coronary heart disease, including 12 patients with stable angina and 27 patients with acute coronary syndromes (ACS), and 12 patients with noncoronary heart disease. We isolated the circulating microparticles by capture with annexin V and determined their procoagulant potential with a prothrombinase assay. The cell origins of microparticles were determined in an additional 22 patients by antigenic capture with specific antibodies. The level of procoagulant microparticles did not differ between stable angina patients and noncoronary patients (10.1±1.6 nmol/L phosphatidylserine [PS] equivalent versus 9.9±1.6 nmol/L PS equivalent, respectively). However, procoagulant microparticles were significantly elevated in patients with ACS (22.2±2.7 nmol/L PS equivalent) compared with other coronary (PPPConclusions—High levels of procoagulant endothelial microparticles are present in the circulating blood of patients with ACS and may contribute to the generation and perpetuation of intracoronary thrombi.Keywords
This publication has 10 references indexed in Scilit:
- In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulantJCI Insight, 1999
- Bed Rest in Deep Vein Thrombosis and the Incidence of Scintigraphic Pulmonary EmbolismThrombosis and Haemostasis, 1999
- Treatment with a GPIIb/IIIa Antagonist Inhibits Thrombin Generation in Platelet Rich Plasma from PatientsThrombosis and Haemostasis, 1998
- Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles.JCI Insight, 1997
- The significance of shed membrane particles during programmed cell death in vitro, and in vivo, in HIV-1 infection.JCI Insight, 1997
- Tissue-factor antigen and activity in human coronary atherosclerotic plaquesThe Lancet, 1997
- Surface blebs on apoptotic cells are sites of enhanced procoagulant activity: implications for coagulation events and antigenic spread in systemic lupus erythematosus.Proceedings of the National Academy of Sciences of the United States of America, 1996
- Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl.The Journal of Experimental Medicine, 1995
- Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cellsCell, 1995
- The Pathogenesis of Coronary Artery Disease and the Acute Coronary SyndromesThe New England Journal of Medicine, 1992